The brokerage says China’s progress in DUV lithography poses only a limited financial risk and sees the recent selloff as a buying opportunity.
Actualités
Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.
Replimune (NASDAQ: REPL) shares fell nearly 31% on Tuesday after US Food and Drug Administration (FDA) staff reviewers raised concerns over the effectiveness of the company’s lead cancer therapy, RP1, ahead of a key advisory committee meeting. The decline followed the release of FDA briefing...
The payout resolves a 2021 civil lawsuit brought by newsletter publishers David and Ina Steiner over a 2019 campaign to silence their reporting
A short-seller report accusing Bloom Energy of hiding Chinese supplier reliance has torched 35% of its market value in a month, and tonight's Q2 report may either silence the bears or hand them fresh ammunition.
Three cryptocurrency investors filed a federal lawsuit against Apple (Nasdaq: AAPL) on July 24. They allege they lost a combined $1.8 million in Bitcoin through a fake wallet app listed on the App Store. The complaint was filed in the U.S. District Court for the Northern District of California. It ...
Jim Cramer has a name for quality dividend stocks that crash for no good reason, and buying them at the right moment turns a market panic into a windfall. Only one name on his watchlist currently fits the setup.
Boston expects its restructuring plan to cost between $700m and $800m and be completed by the end of 2029.
Starship looks nearly ready for prime time -- so is SpaceX stock finally a buy?
Well-received earnings from Unilever, Croda and GSK spurred gains on the blue-chip FTSE 100.
BRO misses Q2 earnings estimates as acquisition-driven revenue growth is offset by weaker organic growth and margin pressure.
PayPal Stock Falls Despite an Earnings Beat. Here's What Has Investors Worried
Johnson & Johnson says it will pay an estimated $5.5 billion to settle about 76,000 lawsuits alleging its baby powder and talc caused ovarian cancer.
Optics stocks that soared triple digits this year are getting hammered Tuesday, and the reason traces back to a single line in Alphabet's latest earnings report that traders cannot stop talking about.
Alphabet is determined to win the AI race, but not everyone is convinced.
Stellantis is selling its car-sharing business Free2Move to a German private equity firm as part of a plan to boost profitability.
SNDK stock dropped to an intra-day low of around $1,050 before recovering part of its losses.
WU faces a Q2 revenue decline, but growing Consumer Services and lower expenses could help support earnings despite pressure in money transfers.
The optical fiber specialist reported results that beat expectations, but investors wanted more.
Chip stocks are getting hammered Tuesday while NVIDIA barely budges, and the gap between winners and losers reveals a stark shift in how investors are positioning ahead of the biggest earnings week of the year.
Insider exercised stock options and sold shares under a pre-arranged Rule 10b5-1 trading plan established in March, reducing his equity stake by 35% while retaining nearly 900,000 derivative securities.
Starbucks is widely believed to be in turnaround mode, but margins, growth and earnings expectations have retreated in the two years since Brian Niccol took over. Read more below in today’s Markets A.
Investing.com -- TD Cowen has downgraded Intuit to Hold from Buy, with the firm’s analyst Jared Levine citing a near-term catalyst path that he sees skewing more negative than positive and limiting a recovery in the shares.
Hilton Worldwide Holdings Inc (NYSE:HLT) raised its full-year profit outlook on Tuesday, but shares fell 3.4% after third-quarter guidance came in below Wall Street estimates. The hotel operator now expects full-year adjusted earnings per share of $8.89 to $9.01, up from $8.79 to $8.91...
Beyond Meat hopes it can stem its multiyear sales decline.